Follow
Cristiano Ferlini
Cristiano Ferlini
Verified email at abbvie.com
Title
Cited by
Cited by
Year
Class III β-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients
S Mozzetti, C Ferlini, P Concolino, F Filippetti, G Raspaglio, S Prislei, ...
Clinical Cancer Research 11 (1), 298-305, 2005
4722005
Role of microRNAs in drug-resistant ovarian cancer cells
A Sorrentino, CG Liu, A Addario, C Peschle, G Scambia, C Ferlini
Gynecologic oncology 111 (3), 478-486, 2008
4582008
Defining “mutation” and “polymorphism” in the era of personal genomics
R Karki, D Pandya, RC Elston, C Ferlini
BMC medical genomics 8, 1-7, 2015
3392015
Class III β-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients
G Ferrandina, GF Zannoni, E Martinelli, A Paglia, V Gallotta, S Mozzetti, ...
Clinical cancer research 12 (9), 2774-2779, 2006
3022006
Glofitamab, a novel, bivalent CD20-targeting T-cell–engaging bispecific antibody, induces durable complete remissions in relapsed or refractory B-cell lymphoma: a phase I trial
M Hutchings, F Morschhauser, G Iacoboni, C Carlo-Stella, FC Offner, ...
Journal of Clinical Oncology 39 (18), 1959, 2021
2872021
Inflammatory myofibroblastic tumor (inflammatory pseudotumor): DNA flow cytometric analysis of nine pediatric cases
R Biselli, C Ferlini, A Fattorossi, R Boldrini, C Bosman
Cancer: Interdisciplinary International Journal of the American Cancer …, 1996
2081996
Synthesis of some pyrazole derivatives and preliminary investigation of their affinity binding to P-glycoprotein
F Manna, F Chimenti, R Fioravanti, A Bolasco, D Secci, P Chimenti, ...
Bioorganic & medicinal chemistry letters 15 (20), 4632-4635, 2005
2052005
Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance
C Ferlini, G Raspaglio, S Mozzetti, M Distefano, F Filippetti, E Martinelli, ...
Molecular pharmacology 64 (1), 51-58, 2003
2002003
Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines
C Ferlini, G Scambia, M Marone, M Distefano, C Gaggini, G Ferrandina, ...
British journal of cancer 79 (2), 257-263, 1999
1941999
Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77
C Ferlini, L Cicchillitti, G Raspaglio, S Bartollino, S Cimitan, C Bertucci, ...
Cancer research 69 (17), 6906-6914, 2009
1782009
Flow cytometric analysis of the early phases of apoptosis by cellular and nuclear techniques
C Ferlini, S Di Cesare, G Rainaldi, W Malorni, P Samoggia, R Biselli, ...
Cytometry: The Journal of the International Society for Analytical Cytology …, 1996
1551996
Hypoxia induces class III beta-tubulin gene expression by HIF-1α binding to its 3'flanking region
G Raspaglio, F Filippetti, S Prislei, R Penci, I De Maria, L Cicchillitti, ...
Gene 409 (1-2), 100-108, 2008
1532008
In vitro evaluation of newly developed chalcone analogues in human cancer cells
R De Vincenzo, C Ferlini, M Distefano, C Gaggini, A Riva, E Bombardelli, ...
Cancer chemotherapy and pharmacology 46, 305-312, 2000
1382000
The seco-taxane IDN5390 is able to target class III β-tubulin and to overcome paclitaxel resistance
C Ferlini, G Raspaglio, S Mozzetti, L Cicchillitti, F Filippetti, D Gallo, ...
Cancer research 65 (6), 2397-2405, 2005
1342005
MiR-200c and HuR in ovarian cancer
S Prislei, E Martinelli, M Mariani, G Raspaglio, S Sieber, G Ferrandina, ...
BMC cancer 13, 1-14, 2013
1242013
Silybin and its bioavailable phospholipid complex (IdB 1016) potentiate in vitro and in vivo the activity of cisplatin
S Giacomelli, D Gallo, P Apollonio, C Ferlini, M Distefano, P Morazzoni, ...
Life sciences 70 (12), 1447-1459, 2002
1242002
Antitumour activity of the silybin-phosphatidylcholine complex, IdB 1016, against human ovarian cancer
D Gallo, S Giacomelli, C Ferlini, G Raspaglio, P Apollonio, S Prislei, ...
European Journal of Cancer 39 (16), 2403-2410, 2003
1232003
Myofibroblastic tumours: neoplasias with divergent behaviour. Ultrastructural and flow cytometric analysis
R Biselli, R Boldrini, C Ferlini, C Boglino, A Inserra, C Bosman
Pathology-Research and Practice 195 (9), 619-632, 1999
1161999
Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma
I De Stefano, G Raspaglio, GF Zannoni, D Travaglia, MG Prisco, M Mosca, ...
Biochemical Pharmacology 78 (11), 1374-1381, 2009
1122009
The novel trinuclear platinum complex BBR3464 induces a cellular response different from cisplatin
T Servidei, C Ferlini, A Riccardi, D Meco, G Scambia, G Segni, C Manzotti, ...
European Journal of Cancer 37 (7), 930-938, 2001
1072001
The system can't perform the operation now. Try again later.
Articles 1–20